Skip to main content
Premium Trial:

Request an Annual Quote

"Next Generation" Internet Will Be Used For Bioinformatics


OTTAWA--One of the first applications of the new broadband CA*net II network, launched here last month as the "first next-generation internet in the world," will be in bioinformatics. A bioinformatics research project of the National Research Council will help demonstrate CA*net II's ability to support collaborative research activities, according to Andrew Bjerring, CEO of CANARIE Inc., CA*net II's developer, a nonprofit consortium of businesses, research institutes, and the Canadian government charged with creating next-generation networking technology in Canada.

CA*net II is built on asynchronous transfer mode telecommunications facilities and is designed to support high-speed multimedia applications. In addition to bioinformatics, other initial applications will include long-distance education and telemedicine services.

CA*net II was developed in partnership with several Canadian telecommunications companies. It is already linked to advanced internet networks in the U.S., and will be connected to its counterparts in Europe and Asia by the end of the year, Bjerring said.

Filed under

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.